Unknown

Dataset Information

0

Consumption of Roasted Coffee Leads to Conjugated Metabolites of Atractyligenin in Human Plasma.


ABSTRACT: Roasted coffee contains atractyligenin-2-O-β-d-glucoside and 3'-O-β-d-glucosyl-2'-O-isovaleryl-2-O-β-d-glucosylatractyligenin, which are ingested with the brew. Known metabolites are atractyligenin, atractyligenin-19-O-β-d-glucuronide (M1), 2β-hydroxy-15-oxoatractylan-4α-carboxy-19-O-β-d-glucuronide (M2), and 2β-hydroxy-15-oxoatractylan-4α-carboxylic acid-2-O-β-d-glucuronide (M3), but the appearance and pharmacokinetic properties are unknown. Therefore, first time-resolved quantitative data of atractyligenin glycosides and their metabolites in plasma samples from a pilot human intervention study (n = 10) were acquired. None of the compounds were found in the control samples and before coffee consumption (t = 0 h). After coffee, neither of the atractyligenin glycosides appeared in the plasma, but the aglycone atractyligenin and the conjugated metabolite M1 reached an estimated cmax of 41.9 ± 12.5 and 25.1 ± 4.9 nM, respectively, after 1 h. M2 and M3 were not quantifiable until their concentration enormously increased ≥4 h after coffee consumption, reaching an estimated cmax of 2.5 ± 1.9 and 55.0 ± 57.7 nM at t = 10 h. The data suggest that metabolites of atractyligenin could be exploited to indicate coffee consumption.

SUBMITTER: Lang R 

PROVIDER: S-EPMC10722499 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Consumption of Roasted Coffee Leads to Conjugated Metabolites of Atractyligenin in Human Plasma.

Lang Roman R   Czech Coline C   Haas Melanie M   Skurk Thomas T  

Journal of agricultural and food chemistry 20231130 49


Roasted coffee contains atractyligenin-2-<i>O</i>-β-d-glucoside and 3'-<i>O</i>-β-d-glucosyl-2'-<i>O</i>-isovaleryl-2-<i>O</i>-β-d-glucosylatractyligenin, which are ingested with the brew. Known metabolites are atractyligenin, atractyligenin-19-<i>O</i>-β-d-glucuronide (<b>M1</b>), 2β-hydroxy-15-oxoatractylan-4α-carboxy-19-<i>O</i>-β-d-glucuronide (<b>M2</b>), and 2β-hydroxy-15-oxoatractylan-4α-carboxylic acid-2-<i>O</i>-β-d-glucuronide (<b>M3</b>), but the appearance and pharmacokinetic propert  ...[more]

Similar Datasets

| S-EPMC7558450 | biostudies-literature
| S-EPMC5900739 | biostudies-literature
| S-EPMC8729408 | biostudies-literature
| S-EPMC8617352 | biostudies-literature
| S-EPMC9117639 | biostudies-literature
| S-EPMC6628446 | biostudies-literature
| S-EPMC7663408 | biostudies-literature
| S-EPMC7070527 | biostudies-literature
| S-EPMC4834475 | biostudies-literature
| S-EPMC7809118 | biostudies-literature